fda compounding semaglutide crackdown october 2025 July 29, 2024: issued new alert about compounded – Partnership for Safe Medicines Compound versions of GLP-1 drugs

While the connection is still under investigation and has not been conclusively proven, our team is closely monitoring the ongoing research

Metformin: An Old But Still the Best Treatment for Type 2 Diabetes

Why Tirzepatide Tolerates More Site Variability Because tirzepatide activates both GIP and GLP-1 receptors, its therapeutic effect is quite robust, even if absorption varies slightly between injection sites

Patients with chronic thyroiditis who are both negative for TgAb and TPOAb have a higher FT4 and lower TSH with a more moderate clinical picture than antibody-positive cases 14

Calming sensitivity and protecting the barrier

The Impact of Low-dose Gliclazide on the Incretin Effect and Indices of Beta-cell Function